106 Publications (Page 1 of 5)
2014
Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissection.
Rice, Kevin RBeck, Stephen D WBihrle, RichardCary, K ClintEinhorn, Lawrence H and Foster, Richard S
The Journal of urology, vol. 192, (no. 5), pp. 1397-1402, November 2014. | Journal Article
2013
Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.
Cary, K CBeck, Stephen DBihrle, Richard and Foster, Richard S
The Journal of urology, vol. 189, (no. 3), pp. 812-7, 2013/Mar. | Journal Article
 
Serum tumor markers in testicular cancer.
Ehrlich, YaronBeck, Stephen DFoster, Richard SBihrle, Richard and Einhorn, Lawrence H
Urologic oncology, vol. 31, (no. 1), pp. 17-23, 2013/Jan. | Journal Article
2010
Division of prostatic anterior fibromuscular stroma reduces urethral resistance in an ex vivo human prostate model.
Ehrlich, YaronFoster, Richard SBihrle, RichardCheng, LiangTong, Yan and Koch, Michael O
Urology, vol. 76, (no. 2), pp. 511.e10-3, 2010/Aug. | Journal Article
 
Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection.
Beck, Stephen DBey, Aaron LBihrle, Richard and Foster, Richard S
The Journal of urology, vol. 184, (no. 5), pp. 2078-80, 2010/Nov. | Journal Article
 
Is retroperitoneal histology predictive of liver histology at concurrent post-chemotherapy retroperitoneal lymph node dissection and hepatic resection?
Jacobsen, Niels-Erik BBeck, Stephen DJacobson, Lewis EBihrle, RichardEinhorn, Lawrence H and Foster, Richard S
The Journal of urology, vol. 184, (no. 3), pp. 949-53, 2010/Sep. | Journal Article
 
Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer.
Bahler, Clint DFoster, Richard SBihrle, RichardBeck, Stephen DGardner, Thomas ASundaram, Chandru PMasterson, Timothy ACheng, Liang and Koch, Michael O
BJU international, vol. 105, (no. 10), pp. 1372-6, 2010/May. | Journal Article
2009
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
Beck, StephenBeck, Stephen DFoster, Richard SFoster, RichardBihrle, RichardBihrle, RichardEinhorn, Lawrence HEinhorn, LawrenceDonohue, John and Donohue, John P
The Journal of urology, vol. 181, (no. 6), pp. 2526-32, 2009/Jun. | Journal Article
 
Role of routine stentograms following urinary diversion in modern practice.
Regan, Stanton MBeck, Stephen DBihrle, Richard and Foster, Richard S
The Canadian journal of urology, vol. 16, (no. 3), pp. 4660-3, 2009/Jun. | Journal Article
 
Use of ileum as ureteral replacement in urological reconstruction.
Armatys, Sandra AMellon, Matthew JBeck, Stephen DKoch, Michael OFoster, Richard S and Bihrle, Richard
The Journal of urology, vol. 181, (no. 1), pp. 177-81, 2009/Jan. | Journal Article
2008
Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
Brown, James ABrown, JamesBihrle, RichardBihrle, RichardFoster, Richard S and Foster, Richard
Urology, vol. 71, (no. 5), pp. 911-4, 2008/May. | Journal Article
2007
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
Beck, Stephen DCheng, LiangBihrle, RichardDonohue, John P and Foster, Richard S
The Journal of urology, vol. 177, (no. 3), pp. 944-6, 2007/Mar. | Journal Article
 
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Beck, Stephen D. WBeck, Stephen DKarakiewicz, P.I.Hutterer, G.C.Foster, Richard SFoster, Richard SBihrle, RichardTrinh, Q.-D.Bihrle, RichardDonohue, John PDonohue, John PJeldres, C.Einhorn, Lawrence HEinhorn, Lawrence HPerrotte, P.Gallina, A.Tostain, J. and Patard, J.-J.
Cancer, vol. 110, (no. 6), pp. 1235-1240, 2007. | Journal Article
 
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
Beck, Stephen DFoster, Richard SBihrle, RichardEinhorn, Lawrence H and Donohue, John P
The Urologic clinics of North America, vol. 34, (no. 2), pp. 219-25; abstract ix-x, 2007/May. | Journal Article
 
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
Beck, Stephen DPeterson, Matthew DBihrle, RichardDonohue, John P and Foster, Richard S
The Journal of urology, vol. 178, (no. 2), pp. 504-6; discussion 506, 2007/Aug. | Journal Article
 
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck, Stephen DFoster, Richard SBihrle, Richard and Donohue, John P
Urology, vol. 69, (no. 3), pp. 557-9, 2007/Mar. | Journal Article
2005
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?
Beck, Stephen DFoster, Richard SBihrle, RichardCheng, Liang and Donohue, John P
The Journal of urology, vol. 174, (no. 4 Pt 1), pp. 1287-90; discussion 1290, 2005/Oct. | Journal Article
 
Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?
Armatys, Sandra AKoch, Michael OBihrle, RichardGardner, Thomas A and Cheng, Liang
BJU international, vol. 96, (no. 6), pp. 777-80, 2005/Oct. | Journal Article
 
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
Beck, Stephen DBeck, StephenFoster, RichardFoster, Richard SBihrle, RichardBihrle, RichardEinhorn, Lawrence HEinhorn, LawrenceDonohue, John P and Donohue, John
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 23, (no. 25), pp. 6149-56, 2005/Sep/1. | Journal Article
 
Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.
Beck, Stephen DBeck, Stephen D.WFoster, Richard SFoster, Richard SBihrle, RichardBihrle, RichardEinhorn, Lawrence HEinhorn, Lawrence HDonohue, John P and Donohue, John P
Urologic oncology, vol. 23, (no. 6), pp. 423-30, 2005 Nov-Dec. | Journal Article
 
The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
Cheng, LiangKoch, Michael OJuliar, Beth EDaggy, Joanne KFoster, Richard SBihrle, Richard and Gardner, Thomas A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. , vol. 23, (no. 13), pp. 2911-7, 2005/May/1. | Journal Article
2004
Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
Mosharafa, Ashraf AFoster, Richard SKoch, Michael OBihrle, Richard and Donohue, John P
The Journal of urology, vol. 171, (no. 5), pp. 1839-41, 2004/May. | Journal Article
 
Secondary surgery in germ cell tumors--when and how extensively should it be performed?
Foster, Richard SBeck, Stephen D and Bihrle, Richard
World Journal of Urology, vol. 22, (no. 1), pp. 37-40, Apr 2004. | Journal Article
2003
Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy.
Brandli, D WKoch, Michael OFoster, Richard SBihrle, Richard and Gardner, Thomas A
BJU International, vol. 92, (no. 1), pp. 19-22; discussion 22-3, 2003/Jul. | Journal Article
 
Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Mosharafa, Ashraf AMosharafa, Ashraf AFoster, Richard SFoster, Richard SBihrle, RichardBihrle, RichardKoch, Michael OKoch, Michael OUlbright, Thomas MUlbright, Thomas MEinhorn, Lawrence HEinhorn, Lawrence HDonohue, John P and Donohue, John P
Cancer, vol. 98, (no. 4), pp. 753-7, 2003/Aug/15. | Journal Article